PT1267833E - Preparacoes farmaceuticas e sua preparacao - Google Patents

Preparacoes farmaceuticas e sua preparacao

Info

Publication number
PT1267833E
PT1267833E PT01917326T PT01917326T PT1267833E PT 1267833 E PT1267833 E PT 1267833E PT 01917326 T PT01917326 T PT 01917326T PT 01917326 T PT01917326 T PT 01917326T PT 1267833 E PT1267833 E PT 1267833E
Authority
PT
Portugal
Prior art keywords
preparations
particles
emulsion
active substance
active
Prior art date
Application number
PT01917326T
Other languages
English (en)
Inventor
Michael Tobyn
John Nicholas Staniforth
Cheryl Julia Clinch
Robert Price
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1267833(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of PT1267833E publication Critical patent/PT1267833E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT01917326T 2000-04-05 2001-04-05 Preparacoes farmaceuticas e sua preparacao PT1267833E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008411.1A GB0008411D0 (en) 2000-04-05 2000-04-05 Pharmaceutical preparations and their manufacture

Publications (1)

Publication Number Publication Date
PT1267833E true PT1267833E (pt) 2004-11-30

Family

ID=9889294

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01917326T PT1267833E (pt) 2000-04-05 2001-04-05 Preparacoes farmaceuticas e sua preparacao

Country Status (22)

Country Link
US (2) US20030157182A1 (pt)
EP (1) EP1267833B1 (pt)
JP (1) JP2003528907A (pt)
KR (1) KR20030011816A (pt)
CN (1) CN1420764A (pt)
AT (1) ATE269057T1 (pt)
AU (1) AU4440601A (pt)
BR (1) BR0109802A (pt)
CA (1) CA2404367A1 (pt)
DE (1) DE60103865T2 (pt)
DK (1) DK1267833T3 (pt)
ES (1) ES2218402T3 (pt)
GB (1) GB0008411D0 (pt)
HU (1) HUP0300334A3 (pt)
IL (1) IL152074A0 (pt)
MX (1) MXPA02009797A (pt)
NO (1) NO20024737L (pt)
PL (1) PL357808A1 (pt)
PT (1) PT1267833E (pt)
TR (1) TR200401567T4 (pt)
WO (1) WO2001074332A1 (pt)
ZA (1) ZA200207508B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
JP5243247B2 (ja) * 2005-07-28 2013-07-24 アイエスピー インヴェストメンツ インコーポレイテッド スプレー乾燥された粉体及び粒状化された材料の特性の改良方法、並びにそれによって製造した製品
JP2007326083A (ja) * 2006-06-09 2007-12-20 Fujifilm Corp 固体微粒子及びその製造方法
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
CN101541415B (zh) * 2006-11-14 2012-08-22 巴斯夫欧洲公司 生产亚微核/壳粒子的微悬浮乳液或悬浮液的方法
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
EP2125938A2 (en) * 2007-01-26 2009-12-02 Isp Investments Inc. Formulation process method to produce spray dried products
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
MX2011000410A (es) 2008-07-18 2011-03-24 Prosonix Ltd Proceso para mejorar la cristalinidad de particulas de fluticasona.
CN102107127B (zh) * 2011-01-11 2015-04-22 西安蓝晓科技新材料股份有限公司 一种粉体造粒技术
EP2731627A4 (en) * 2011-07-15 2015-06-17 Eupharma Pty Ltd ORAL COMPOSITIONS WITH ANTAZID, ANESTHETIC AND INORGANIC MATRIX WITH SILICON DIOXIDE AND TITANIUM DIOXIDE
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
JP6832950B2 (ja) * 2016-11-10 2021-02-24 日本たばこ産業株式会社 球状の粉末凝集体及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
EP1649850A1 (en) * 1993-11-19 2006-04-26 Alkermes Controlled Therapeutics Inc. II Preparation of biodegradable microparticles containing a biologically active agent
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions

Also Published As

Publication number Publication date
BR0109802A (pt) 2003-01-21
US20030157182A1 (en) 2003-08-21
AU4440601A (en) 2001-10-15
EP1267833A1 (en) 2003-01-02
GB0008411D0 (en) 2000-05-24
NO20024737D0 (no) 2002-10-02
CN1420764A (zh) 2003-05-28
TR200401567T4 (tr) 2004-08-23
PL357808A1 (en) 2004-07-26
ATE269057T1 (de) 2004-07-15
IL152074A0 (en) 2003-05-29
DE60103865D1 (de) 2004-07-22
DE60103865T2 (de) 2004-10-28
ZA200207508B (en) 2003-09-19
DK1267833T3 (da) 2004-07-19
HUP0300334A2 (hu) 2003-09-29
US20100015234A1 (en) 2010-01-21
EP1267833B1 (en) 2004-06-16
CA2404367A1 (en) 2001-10-11
JP2003528907A (ja) 2003-09-30
KR20030011816A (ko) 2003-02-11
NO20024737L (no) 2002-11-18
ES2218402T3 (es) 2004-11-16
WO2001074332A1 (en) 2001-10-11
MXPA02009797A (es) 2004-09-13
HUP0300334A3 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
PT1267833E (pt) Preparacoes farmaceuticas e sua preparacao
MA26800A1 (fr) Systemes et methodes aerosoles pour formulations pharmaceutiques.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
DK0737064T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer af hydrofobe stoffer
WO2002043702A3 (en) Pharmaceutical compositions for inhalation
NL300109I1 (nl) Kristalmodificatie van CDCH, werkwijze voor de bereiding ervan en van farmaceutische preparaten die deze modificaties bevatten.
NL300057I1 (nl) Farmacologisch actieve 1,5-diaryl-3-gesubstitueerde-pyrazolen en werkwijze voor het synthetiseren e rvan.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DE59610469D1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
WO2004041202A3 (en) Analysis of pharmaceutical solubility and stability
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
ATE297195T1 (de) Nanopartikeln für die perorale verabreichung von schwerlöslichen arzneimittel
FR2802812B1 (fr) Utilisation de residus issus de la fabrication du vin pour la fabrication de preparations cosmetiques et/ou pharmaceutiques.
WO2000003724A1 (fr) Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
DZ1926A1 (fr) Formulations pharmaceutiques.
ATE258045T1 (de) Verfahren zu herstellung von pulverförmigen solubilisationshilfsstoffen für feste pharmazeutische darreichungsformen
HRP20000781B1 (en) Effervescent preparations
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
NL7909200A (nl) N-gesubstitueerde trifluorethylaminen, farmaceutische preparaten met als werkzaam bestanddeel een dergelijk n-gesubstitueerd trifluorethylamine erin, alsmede werkwijzen voor de bereiding van de werkzame bestand- delen.
CA2273272A1 (en) Immediate release drug delivery forms
IT8947678A0 (it) Procedimento per la produzione di una proteina endotossica, gene strutturale impiegato e composizioni insetticide comprendenti detta proteina
NO20004816L (no) Ny farmasøytisk formulering